
Sports Medicine
Mesenchymal stem cell vs. chondrocyte implantation for repair of chondral knee defects
Arch Orthop Trauma Surg. 2015 Feb;135(2):251-63.14 patients with isolated single full-thickness femoral condylar chondral defects of the knee (>2 cm-squared in area) qualifying for cartilage repair surgery were randomized to receive either matrix-induced autologous mesenchymal stem cell implantation (m-AMI), or matrix-induced autologous chondrocyte implantation (m-ACI). The purpose of this study was to evaluate and compare the objective and subjective functional, radiological and clinical outcomes from the use of both grafts. Strength testing, knee motion, Knee Injury and Osteoarthritis Outcome Scores. Tegner scores, pain and MOCART scoring were assessed preoperatively, and 6, 12 and 24 months postoperatively. The findings of this trial indicate that the both grafts successfully repaired chondral defects.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now

Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.